Biotech AI Stocks
Discover investment opportunities in Biotech AI Stocks using our Smart AI Filter.
AI is processing your request...
AI is analyzing your request
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Biotech AI Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Biotech AI Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Biotech AI Stocks using our Smart AI Filter.
8 stocks found for "Biotech AI Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
---|---|---|---|---|---|---|
1.34 | ±55.5% | -10.4 | 0.00% | |||
0.83 | ±70.5% | -3.5 | 0.00% | |||
1.19 | ±53.7% | -156.9 | 0.00% | |||
1.54 | ±100.0% | -3.3 | 0.00% | |||
0.30 | ±26.0% | 12.1 | 0.66% | |||
0.61 | ±31.4% | 19.2 | 0.00% | |||
0.36 | ±26.9% | 24.5 | 0.00% | |||
0.89 | ±41.9% | 22.8 | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: What makes NVIDIA (NVDA) attractive in the biotech AI sector?
A: NVIDIA is renowned for its advanced GPU technology, crucial for AI-processing tasks. In biotech, these capabilities facilitate complex data analysis and machine learning applications, potentially providing NVIDIA with a competitive edge as demand for biotech AI solutions grows.
Q: How does Illumina (ILMN) fit into the biotech AI sphere?
A: Illumina is a leader in genomic sequencing technology. Its innovative platforms employ AI to improve data analysis and interpretation, enhancing its appeal to investors interested in cutting-edge biotech applications.
Q: Why is Regeneron Pharmaceuticals (REGN) considered a significant player in AI-driven biotech?
A: Regeneron utilizes AI to bolster its drug discovery and development processes. This integration of AI aims to increase efficiency and accuracy in research, which may enhance its competitive positioning in the biotech sector.
Q: What growth opportunities does Vertex Pharmaceuticals (VRTX) present in biotech AI?
A: Vertex Pharmaceuticals is focused on developing transformative medicines, employing some AI technologies to optimize its research processes. This may suggest potential for growth as biotech increasingly leverages AI innovations.
Q: Why is CRISPR Therapeutics (CRSP) of interest regarding AI and biotech?
A: CRISPR Therapeutics pioneers gene-editing technologies, incorporating AI to improve efficiency in genetic engineering. This integration may offer advantages in speed, precision, and scalability of edits.
Q: How does BEAM Therapeutics (BEAM) integrate AI into its biotech strategies?
A: BEAM Therapeutics focuses on base editing technologies and may use AI for designing and optimizing genetic edits. This approach can improve targeting accuracy and reduce unintended edits.